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Phosphorylation of Rab-coupling protein by LMTK3
controls Rab14-dependent EphA2 trafficking to
promote cell:cell repulsion
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The Rab GTPase effector, Rab-coupling protein (RCP) is known to promote invasive behaviour
in vitro by controlling integrin and receptor tyrosine kinase (RTK) trafficking, but how RCP
influences metastasis in vivo is unclear. Here we identify an RTK of the Eph family, EphA2, to
be a cargo of an RCP-regulated endocytic pathway which controls cell:cell repulsion and
metastasis in vivo. Phosphorylation of RCP at Ser435 by Lemur tyrosine kinase-3 (LMTK3)
and of EphA2 at Ser897 by Akt are both necessary to promote Rab14-dependent (and
Rab11-independent) trafficking of EphA2 which generates cell:cell repulsion events that drive
tumour cells apart. Genetic disruption of RCP or EphA2 opposes cell:cell repulsion and
metastasis in an autochthonous mouse model of pancreatic adenocarcinoma—whereas
conditional knockout of another RCP cargo, a5 integrin, does not suppress pancreatic cancer
metastasis—indicating a role for RCP-dependent trafficking of an Eph receptor to drive
tumour dissemination in vivo.
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T
he Rab family of GTPases and their effector proteins,
which control endosomal trafficking, often have altered
expression in tumours and, in some cases, this can drive
tumour aggressiveness1–4. The Rab11 effector, Rab-coupling
protein (RCP) is a component of the 8p11–12 amplicon which
is commonly amplified in luminal-type breast cancers, and
increased RCP expression has been shown to drive aggressiveness
in this tumour type5. Furthermore, RCP is expressed at elevated
levels in head and neck squamous cell carcinoma6, colon cancers4
and non-small cell lung carcinoma7. RCP regulates transferrin
trafficking8 and in macrophages is thought to control recycling
from phagosomes9. More recent work has shown that mutant
p53 drives invasive migration of cancer cells by activating
RCP-dependent trafficking of a5b1 integrin and receptor tyrosine
kinases10,11.
The capacity of cells to repel one another is likely to contribute
to cell dissemination in both normal and pathophysiological
situations. Indeed, it is now considered likely that during
metastasis homotypic repulsion between cancer cells is
promoted—encouraging cancer cells to move away from the
primary tumour and disperse, while heterotypic repulsion
between cancer and non-cancerous cells is suppressed—
allowing cancer cells to migrate into the surrounding
tissue12–15. Repulsive cues are normally initiated by engagement
of particular cell surface receptors with their cognate ligands
situated at the plasma membrane of neighbouring cells. Many
receptor:ligand pairs that mediate cell:cell repulsion are
upregulated and/or modified in cancer. A recent large-scale
exon sequencing and copy number analysis has indicated that
ligand:receptor pairs of the semaphorin:plexin and ephrin:Eph
families are associated with aggressiveness of pancreatic
adenocarcinoma (PDAC)16. Although there is some dispute
over the role of Ephs and ephrins in early tumorigenesis, it is
generally thought that Ephs, in particular EphA2, are drivers of
invasion and metastasis. In oesophageal squamous cell
carcinoma17 and breast cancer18 high EphA2 expression
correlates with poor prognosis, and EphA2 knockout reduces
tumour growth and metastasis in ErbB2-driven breast cancer in
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Figure 1 | EphA2 associates with RCP. (a) A2780 cells expressing GFP-RCP or GFP control were lysed in a buffer containing 0.15% Tween-20. GFP was
immunoprecipitated from lysates using magnetic beads conjugated to an antibody recognizing GFP. Immunoprecipitated proteins were separated by
SDS-PAGE. and visualized using Coomassie brilliant blue (CBB). GFP-RCP and a5-integrin were detected by immunoblotting (IB) as indicated. (b) A2780
cells were transfected with GFP and GFP-RCP or EphA2-GFP (upper panels) or were left untransfected (lower panel). Cells were lysed in a buffer containing
0.15% Tween-20 and lysates were incubated with magnetic beads conjugated to antibodies recognizing GFP (upper panels) or EphA2 (lower panel).
The immunoprecipitates were analysed by immunoblotting using antibodies recognizing RCP and EphA2. (c,d) EphA2 was immunoprecipitated from H1299
(c) and PC3 (d) cells as for (b) and the immunoprecipitates analysed by immunoblotting for RCP, Rab11 and EphA2. Uncropped blots corresponding to the
experiments presented in c,d are displayed in Supplementary Fig. 8.
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mice. More recently Eph:ephrin interaction has been found to
initiate cell:cell repulsion in prostate cancer cells in a way that
would be expected to drive invasion and metastasis19. As with
other receptor tyrosine kinases, it is likely that Eph receptor
function is influenced by trafficking through the endosomal
system. Indeed, one recent study reports that EphA2 is regulated
by proteolytic cleavage at the cell surface, which allows the
receptor to be internalized to activate signalling responses at
endosomal membranes20.
Here, we identify a novel pathway in which a transmembrane
serine/threonine kinase (LMTK3) phosphorylates a Rab
effector (RCP) to control EphA2 trafficking. This initiates
EphA2-mediated cell:cell repulsion, thus enabling cancer cells to
move away from each other. In parallel with this we show that
RCP and EphA2 are required for efficient invasion and metastasis
in an in vivo model of PDAC suggesting that cell-cell repulsion is
an important step in the metastatic spread of cancer.
Results
EphA2 associates with RCP. To search for new cargoes of
endocytic recycling pathways that drive cancer cell migration and
invasion, we screened RCP’s interactome using immunoprecipi-
tation and mass spectrometry. A number of proteins specifically
associated with RCP and these included known interactors, such
as a5b1 integrin, EGFR1, Rab11 and Rab14, but also receptors
that may represent new RCP cargoes (Fig. 1a,Table 1). EphA2
was abundant in RCP immunoprecipitates, and we confirmed
its co-precipitation with endogenous and GFP-tagged RCP
(irrespective of whether EphA2 or RCP was the bait), in a range
of cancer cell lines (Fig. 1b-d).
RCP is required for efficient cell repulsion. Given EphA2’s
association with RCP, we determined the requirement for Rab
GTPase-controlled endosomal trafficking in cell repulsion. When
PC3 cells are treated with hepatocyte growth factor (HGF),
they migrate rapidly on Matrigel-coated surfaces and numerous
examples of cell repulsion may be observed. For example,
in Fig. 2a, two PC3 cells migrated towards one another (green
arrows), and upon collision (0min) they stopped migrating for
several minutes (Supplementary Movies 1 and 2). The cells then
migrated away from each other in a direction that was different
from their approach (red arrow). Quantification of a large
number of collisions indicated that RCP knockdown significantly
increased the time that colliding cells remained in contact before
migrating away from one another, while siRNA of other Rab11
effectors (Fip2 or Fip3) or RCP interactors (a5b1 integrin) was
ineffective in this regard (Fig. 2b,c; Supplementary Fig. 1a).
Moreover, siRNA of RCP reduced the difference between the
direction of cell migration before and after the collision,
indicating the decreased tendency of RCP knockdown cells to
change direction following collisions (Fig. 2a; Supplementary
Movies 1 and 2). RCP knockdown did not affect migration speed
of non-colliding cells (Fig. 2b), indicating that this Rab effector
plays a role in cell repulsion in a manner which is distinct from
the regulation of cell migration per se.
As cell:cell repulsion is likely to contribute to cancer cell
dissemination, we tested the requirement for EphA2 and RCP in
cell scattering. H1299 non-small cell lung cancer cells grow in
tight colonies which scatter rapidly following addition of HGF
(Fig. 2d). Time-lapse/cell tracking indicated that knockdown of
either EphA2 or RCP (Fig. 2d–f; Supplementary Fig. 1b) strongly
suppressed cell scattering. Interestingly, HGF-driven migration of
sparsely plated non-contacting H1299 cells was not influenced by
knockdown of RCP or EphA2 (Supplementary Fig. 2a) indicating
that the cell migratory machinery was not, per se, inhibited by
EphA2 or RCP knockdown and demonstrating that the role of
these proteins in cell scattering is owing to their contribution to
cell:cell repulsion.
RCP and Rab14 control EphA2 trafficking and function. To
obtain estimates of EphA2 internalization that were unaffected by
receptor recycling, we performed endocytosis assays in the
presence of the recycling inhibitor, primaquine. This indicated
that neither HGF-addition nor RCP-knockdown affected EphA2
Table 1 | Proteomic analysis of GFP-RCP immunoprecipitates.
Protein Accession number IP:GFP IP:GFP-RCP
Number of
peptides (unique)
Percentage
covered (%)
Number of
peptides (unique)
Percentage
covered (%)
Ubiquitin P62988 — — 4 (3) 50
Rab11B Q15907 — — 53 (8) 40
Heat shock cognate 71 kDa P11142 1 (1) 3 43 (16) 32
Rab6A P20340 — — 18 (5) 25
a-actinin 4 O43707 — — 32 (16) 23
Rab11-FIP1 (RCP) Q6WKZ4 — — 60 (17) 16
Clathrin heavy chain 1 Q00610 — — 27 (15) 13
Rab11-FIP5 Q9BXF6 — — 11 (5) 13
Rab14 P61106 — — 6 (2) 13
5’-nucleotidase P21589 1 (1) 2 9 (5) 13
Myoferlin Q9NZM1 — — 34 (20) 12
Aminopeptidase N P15144 — — 21 (9) 12
Ephrin type-A receptor 2 (EphA2) P29317 — — 18 (9) 12
Peroxisomal multifunctional enzyme type 2 P51659 — — 11 (5) 10
Desmoglein 2 Q14126 — — 8 (6) 10
Myeloid-associated differentiation marker Q96S97 — — 8 (2) 10
Heat shock 70 kDa protein 1 P08107 — — 3 (3) 10
b1 integrin P05556 1 (1) 1 17 (5) 9
EGFR P00533 — — 17 (7) 8
Neurabin 2 Q96SB3 — — 7 (6) 8
4F2 cell-surface antigen heavy chain P08195 — — 3 (3) 8
Immunoprecipitates generated in Fig. 1a were analysed by MALDI-TOF mass spectrometry. Proteins that were significantly more abundant in GFP-RCP (IP:GFP-RCP) than GFP (IP:GFP)
immunoprecipitates are listed. The number of peptides identified by mass spectrometry and the percentage of these proteins covered by the identified peptides are indicated.
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endocytosis per se (Fig. 3a). In the absence of primaquine,
however, addition of HGF significantly enhanced the rate of
EphA2 accumulation within H1299 cells (Fig. 3b). These data
indicate that HGF does not affect EphA2 endocytosis, but reduces
the rate at which internalized EphA2 recycles to the cell surface.
Importantly, HGF’s ability to promote intracellular accumulation
of EphA2 was partially reversed by RCP knockdown (Fig. 3b).
HGF-addition significantly increased the quantity of EphA2
that coimmunoprecipitated with RCP, consistent with a func-
tional role for RCP in EphA2 trafficking (Fig. 3c). RCP can bind
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to Rab14 as well as Rab11 (Table 1) (refs 21,22), so we probed
RCP immunoprecipitates with antibodies recognizing these Rab
GTPases. HGF promoted association of Rab14 with this complex,
suggesting that Rab14 may contribute to EphA2 trafficking
(Fig. 3c). By contrast, the amount of Rab11 which coimmuno-
precipitated with RCP was not reproducibly increased by addition
of HGF (Fig. 3c). Knockdown of Rab14 (but not Rab11)
completely opposed HGF-driven cellular accumulation of EphA2,
indicating that Rab14 is necessary for RCP-mediated EphA2
trafficking (Fig. 3d; Supplementary Fig. 2b).
We expressed EphA2-GFP with mCherry-RCP or mCherry-
Rab14 and monitored the trafficking of these proteins in the
presence and absence of HGF. EphA2-GFP was localized to the
plasma membrane and intracellular vesicles that were in constant
motion and were frequently seen near cell:cell contacts (Fig. 3e;
Supplementary Movie 3). By contrast, mCherry-RCP and
mCherry-Rab14 were localized to the peri-nuclear region,
and there was little co-localization between EphA2-GFP and
mCherry-RCP or mCherry-Rab14 (Fig. 3e,f; Supplementary
Movies 3 and 5). Following addition of HGF, EphA2-GFP
was relocated to RCP- and Rab14-positive structures, and
quantitative analysis indicated that this was statistically significant
across a number of experiments (Fig. 3e,f; Supplementary
Movies 4 and 6). Furthermore, high resolution imaging of fixed
cells indicated that both EphA2-GFP and mCherry-RCP, and
endogenous EphA2 and RCP are present in a subset of closely
apposed perinuclear endosomes that possess both overlapping
and non-overlapping domains (Fig. 3e; Supplementary Fig. 3a,b).
These findings prompted us to investigate the respective
requirements for Rab14 and Rab11 in EphA2-dependent cell:cell
repulsion and scattering. siRNA of Rab14 opposed HGF-driven
cell scattering, whereas knockdown of Rab11 was ineffective in
this regard (Fig. 4a). Consistently, knockdown of Rab14 increased
the time that colliding PC3 cells remained in contact before
migrating away from one another, while siRNA of Rab11 did not
(Fig. 4b; Supplementary Fig. 1a). Moreover, siRNA of Rab14 did
not affect the migration speed of non-contacting cells. Taken
together, these data indicate that signalling events downstream of
HGF promote assembly of an RCP-Rab14 complex which
controls EphA2 trafficking to enable cell:cell repulsion, and that
RCP-Rab11 interaction is not required for this to occur.
LMTK3 phosphorylates RCP to promote cell scattering. As
HGF signalling may control RCP function by influencing its
phosphorylation, we used mass spectrometry to identify residues
in RCP that might function as phospho-acceptors. The most
abundant phospho-peptides in RCP were 430ESRRSS(HPO3)
LLSLMTGK443 and 523RPPISS(HPO3)PRAPQTRA537 (Supplementary
Fig. 4a), and we raised a phospho-specific antibody against a
synthetic peptide corresponding to one of these RCP427-439
(pSer435) (Supplementary Fig. 5b). Addition of staurosporine led
to substantial reduction in the signal detected by anti-pSer435-
RCP (Supplementary Fig. 4b) indicating that RCP phosphoryla-
tion is a dynamic event and therefore potentially regulated.
Indeed, increased phosphorylation of RCP at Ser435 was detected
shortly following addition of HGF to H1299 cells (Fig. 4c).
The region surrounding RCP’s Ser435 conforms to a consensus
sequence for phosphorylation by the transmembrane endosomal
serine/threonine kinase, LMTK2 (ref. 23). The LMTK family
comprises three members, and siRNA experiments indicated that
LMTK3 is responsible for HGF-induced phosphorylation of
RCP’s Ser435. Indeed, siRNA of LMTK3 (Fig. 4c,d), but not
LMTK1 (Fig. 4d) opposed HGF-driven phosphorylation of RCP
at Ser435.
siRNA of LMTK3 (but not LMTK1) or substitution of RCP’s
Ser435 with Ala opposed HGF-driven recruitment of RCP, Rab14
and EphA2 into a coimmunoprecipitatable complex (Fig. 4d).
Moreover, following LMTK3 knockdown or expression of
RCP435A, HGF did not promote intracellular accumulation of
EphA2 (Fig. 5a). Consistently, quantitative live cell imaging
and high resolution fluorescence microscopy indicated that
HGF-driven transport of EphA2 to RCP-positive endosomes
was opposed by siRNA of LMTK3 and by expression of mCherry-
RCP435A (Fig. 5b; Supplementary Fig. 3b). Taken together these
data indicate that HGF signalling promotes LMTK3-mediated
phosphorylation of RCP at Serine435 which leads to assembly of
an RCP/Rab14/EphA2 complex and accumulation of EphA2
within perinuclear endosomes.
Having delineated signalling events leading to altered EphA2
trafficking, we then tested their role in cell repulsion and
scattering. Disruption of LMTK3-mediated RCP phosphoryla-
tion, either by siRNA of LMTK3 or expression of RCP435A
opposed HGF-driven cell scattering (Fig. 5c), without suppressing
the migration speed of non-contacting cells. By contrast,
knockdown of LMTK1 was ineffective in this regard.
Taken together these data identify a pathway linking HGF
signalling to EphA2 trafficking which proceeds via LMTK3-
mediated phosphorylation of RCP and recruitment of Rab14,
and that this pathway must be intact in order for cells to activate
Figure 2 | RCP and EphA2 influence cell:cell repulsion. (a–c) PC3 cells were transfected with siRNAs targeting RCP (SMARTPool (si-RCP) or two
individual oligos (si-RCP#1 and si-RCP#2), FIP2 (si-FIP2), FIP3 (si-FIP3), a5 integrin (si-a5) or a non-targeting control (si-Nt). Transfected cells were
sparsely seeded onto glass-bottomed wells coated with 33%Matrigel. Cells were serum-starved for 24 h and then treated with HGF (10 ngml 1) to initiate
cell migration. Cell movement was recorded using time-lapse video microscopy with frames being collected every 5min. Representative movies illustrate
collisions between control (si-Nt; movie 1) and RCP knockdown (si-RCP; movie 2) cells and frames from these are displayed in a. The frames have been
aligned so that the start of the cell collision is at t¼0min. The green arrows indicate the direction from which the cells approached one another, and the
red arrows indicate the direction of migration after the collision. The time that cells spent touching each other during collision was determined for all
collisions in which only two cells were involved and both cells were migrating towards each other pre-collision (b; left panel and c). The speed of cell
migration between collisions was also calculated from these movies (b; right panel). Bar, 10mm. Data are represented as box and whiskers plots (whiskers:
10–90 percentile,þ represents the mean). ***Po0.001, *Po0.01; one-way ANOVA (Kruskal-Wallis test, Dunn’s Multiple Comparison Test). Data are from
three independent experiments with 450 collisions being tracked per condition. (d–f) H1299 cells were transfected with siRNAs targeting RCP
(SMARTPool (si-RCP) or an individual oligo (si-RCP#1), individual oligos targeting EphA2 (EphA2#1 and EphA2#2) or a non-targeting control (si-Nt).
Transfected cells were seeded onto plastic surfaces and allowed to grow overnight to form colonies of approx. 4 cells per colony. Cells were then treated
with HGF (10 ngml 1) and cell scattering was recorded using time-lapse video microscopy with frames being collected every 5min over a 6 h period.
Representative trackplots of movies illustrate the scattering reaction of control (si-Nt), EphA2 knockdown (si-EphA2) and RCP knockdown (si-RCP)
cells (d). Cell scattering was quantified using ImageJ manual tracking and chemotaxis plugin, and is expressed as the accumulated distance travelled
over 6 h (e,f). Data are represented as box and whiskers plots (whiskers: 10–90 percentile,þ represents the mean). ***Po0.001; one-way ANOVA
(Kruskal-Wallis test, Dunn’s Multiple Comparison Test). Data are from three independent experiments with 450 cells being tracked per condition.
Bar in d, 50mm.
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the repulsive events that allow cells to move away from one
another.
Requirement for phospho-Ser897-EphA2 in cell scattering.
EphA2 functions in ligand-dependent and -independent ways
to influence cell movement. siRNA of ephrin-A1, the cognate
ephrin ligand for EphA2 which is expressed by H1299 cells
(Supplementary Fig. 5a), had no effect on cell scattering,
indicating the possibility that engagement of EphA2 with its
ephrin ligand might not be a key determinant of HGF-driven
cell:cell repulsion. Ligand-engagement of EphA2 is known
to promote phosphorylation of Tyr588 in its cytodomain
(Supplementary Fig. 5b) which triggers ligand-dependent
downstream signalling24. Consistently, occupation of EphA2 with
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ephrin-A1 drives complete redistribution of the receptor from the
cell surface to endosomes, and this is opposed by substitution of
Tyr588 with Phe (Supplementary Fig. 5c). However, mutation of
EphA2’s Tyr588 had no effect on HGF-driven intracellular
accumulation of EphA2 and even increased the basal (ligand-
independent) levels of receptor internalization (Supplementary
Fig. 5d). Moreover, HGF promoted the delivery of EphA2-
Tyr588F to RCP-positive endosomes to a similar extent as seen for
the wild-type receptor (Supplementary Fig. 5e) and, importantly,
EphA2-Tyr588F was fully capable of supporting HGF-driven cell
scattering (Supplementary Fig. 5f).
Some functions of EphA2 are associated with phosphorylation
of Ser897 which occurs following activation of Akt by growth
factor receptors25. Consistent with previous reports, we found
that HGF promoted phosphorylation of EphA2 on Ser897 (but
not Tyr588) (Supplementary Fig. 6a). Moreover, knockdown of
endogenous ephrin-A1 did not affect HGF-driven phospho-
rylation of EphA2’s Ser897 (Supplementary Fig. 6a). To determine
whether trafficking of EphA2 to the RCP/Rab14 compartment
influences EphA2 phosphorylation, we knocked-down RCP,
Rab14 or LMTK3 and measured levels of phospho-Ser897-
EphA2 (EphA2pS897). However, siRNA of these regulators of
EphA2 trafficking did not influence the cellular content of
EphA2pS897 (Supplementary Fig. 6b). Furthermore, we have used
a phosphoproteomic approach to map phosphorylated residues in
EphA2’s cytodomain and have not been able to identify residues
other than Ser897 whose phosphorylation was influenced by HGF
addition. We, therefore, investigated whether phosphorylation
of EphA2 on Ser897 influences its endosomal trafficking.
Substitution of Ser897 with Ala completely opposed HGF-driven
intracellular accumulation of EphA2-GFP (Fig. 6a). Consistently,
quantitative live cell imaging and high resolution microscopy
demonstrated that EphA2897A-GFP was not trafficked to
RCP-positive endosomes following HGF addition (Fig. 6b;
Supplementary Fig. 3b). Furthermore, following HGF-addition,
endogenous EphA2pS897 accumulated in RCP-positive endo-
somes in the perinuclear region of HGF-treated cells, and this was
opposed by siRNA of LMTK3 or Rab14, or by expression of
mCherry-RCP435A (Fig. 6c; Supplementary Fig. 3c). Finally,
although siRNA-resistant EphA2-GFP restored HGF-driven cell
scattering in EphA2 knockdown cells, EphA2-GFP897A was
less effective in this regard (Fig. 6d). Importantly, despite
EphA2-Ser897A’s inability to support cell scattering, this mutant
of EphA2 did not oppose HGF-induced migration of
non-contacting cells (Fig. 6d). Taken together, these data
indicate that Akt-mediated phosphorylation of EphA2 at
Ser897A is required for its trafficking to RCP/Rab14 positive
endosomes and for the consequent activation of cell repulsion.
Requirement for RCP and EphA2 in metastasis of PDAC.
Having described the signalling and trafficking events linking
RCP to EphA2 function in cell:cell repulsion we wished to
determine whether these two proteins contributed to cancer-
relevant processes in an appropriate in vivo context. To do this we
compared the consequences of genetic disruption of RCP and
EPHA2 genes in the ‘KPC’ mouse model of PDAC (ref. 26).
EPHA2 / mice are viable and have no overt developmental
abnormalities. A conditional RCP knockout mouse was generated
that contains a Neomycin cassette flanked by LoxP sites following
exon 2 of RCP (Supplementary Fig. 7a). Western blots confirmed
that RCP expression was abrogated following infection of
embryonic fibroblasts from RCPfl/fl mice with a Cre-expressing
adenovirus (Supplementary Fig. 7b). In the KPC model, the size
of the primary tumour (not the metastases) dictates survival.
Knockout of RCP had no significant effect on the survival of KPC
mice, while EphA2 knockout reduced survival, indicating that
initiation and growth of primary PDACs are not dependent
on expression of either protein (Fig. 7a). However, knockout of
either EPHA2 or RCP significantly reduced the incidence of
metastases in KPC mice (Fig. 7b).
RCP is involved in trafficking of receptors other than EphA2,
and a5b1 integrin is an RCP cargo that controls cell migration
and invasion10,27,28. We, therefore, used a5 integrin (ITGA5)
floxed mice to determine whether this RCP cargo was also
involved in the growth and metastasis of PDAC. Interestingly,
knockout of ITGA5 did not influence growth or metastasis of
PDAC (Fig. 7a,b), indicating that RCP’s ability to traffic EphA2 is
Figure 3 | HGF-driven trafficking of EphA2 is controlled by RCP and Rab14. (a,b) H1299 cells were transfected with siRNAs targeting RCP (si-RCP) or a
non-targeting control (si-Nt) and plated onto 10 cm plastic dishes. Cells were surface-labelled with NHS-S-S-Biotin (0.13mgml 1) at 4 C and
internalization allowed to proceed at 37 C for the indicated times in the presence (a) or absence (b) of primaquine (0.6mM), with or without HGF
(10 ngml 1). Biotin remaining at the cell surface was removed by exposure to MesNa at 4 C and the quantity of biotinylated receptors within the cells
determined by capture-ELISA using microtitre wells coated with monoclonal antibodies recognizing EphA2. Values are mean±s.e.m. from either one
representative experiment performed in quadruplicate (a) or from three independent experiments (b), ***Po0.001 (si-RCPþHGF versus si-NtþHGF);
two-way ANOVA, Bonferroni post-test. (c) H1299 cells expressing GFP-RCP were incubated in the presence or absence of HGF (10 ngml 1) for 1min.
Cells were lysed in a buffer containing 0.15% Tween-20 and GFP was immunoprecipitated as for Fig. 1c. The immunoprecipitates were analysed by
immunoblotting using antibodies recognizing EphA2, Rab14, Rab11 and RCP. Recruitment of EphA2, Rab14 and Rab11 to GFP-RCP immunoprecipitates was
quantified by densitometric scanning of western blots. Values are mean±s.e.m. from three independent experiments; *Po0.05, ***Po0.001, ns, not
significant; Mann-Whitney test. Uncropped blots corresponding to the experiment presented in Fig. 3c are displayed in Supplementary Fig. 9. (d) H1299
cells were transfected with siRNAs targeting Rab14 (si-Rab14) or a non-targeting control (si-Nt) and internalization of EphA2 in the presence and absence
of HGF was determined as for b. Values are mean±s.e.m. from three independent experiments, ***Po0.001 (si-Rab14þHGF versus si-NtþHGF);
two-way ANOVA, Bonferroni post-test. (e,f) H1299 cells were transfected with EphA2-GFP in combination with either mCherry-RCP (e) or mCherry-Rab14
(f) and plated onto glass-bottomed dishes, or were left untransfected. Twenty-four hours following transfection, confocal time-lapse movies were collected
with 2 s frame intervals over a 2min period in the presence and absence of HGF (10 ngml 1). HGF was added 30min before collecting the movies. Stills
were extracted from movies 3-4 at the indicated time points following collection of the first frame of the movie and display the region of interest indicated
by the white boxes. Bar, 10mm. Olympus software was used to quantify co-localized pixels relative to the EphA2-GFP and mCherry-RCP pixels across the
course of the movies, and these are plotted as the fraction of co-localizing pixels as determined by the Costes method39. Values are mean±s.e.m. from
three separate experiments incorporating460 cells per condition, ***Po0.001 Mann-Whitney test. In the right panels in e untransfected H1299 cells were
incubated in the presence or absence of HGF (10 ngml 1) for 30min and then fixed. Endogenous RCP and EphA2 were visualized by immunofluorescence
with respect to the cell nucleus (stained with DAPI) following by high resolution imaging using a high resolution Airy-scan microscope. Detail of the
perinuclear region is displayed. Bar, 1 mm. The whole cell fluorescence micrographs and single channel fluorescence images of these Airy-scan images are
presented in Supplementary Fig. 4a.
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Figure 4 | Rab14 controls cell repulsion and LMTK3 phosphorylates RCP at Ser435. (a) H1299 cells were transfected with siRNAs targeting Rab14
(si-Rab14), Rab11 (si-Rab11) or a non-targeting control (si-Nt) and cell scattering was determined as for Fig. 2d,e. Representative trackplots from these
experiments are displayed and cell scattering was quantified as for Fig. 2e and is expressed as the accumulated distance travelled over 6 h. Data are
represented as box and whiskers plots (whiskers: 10–90 percentile,þ represents the mean). ***Po0.001; one-way ANOVA (Kruskal-Wallis test, Dunn’s
Multiple Comparison Test). Data are from three independent experiments with 450 cells being tracked per condition. Bar, 50mm. (b) PC3 cells were
transfected with siRNAs targeting Rab14, Rab11 or a non-targeting control (si-Nt) and the contact time during collisions (left panel) and migration speed
between collisions (right panel) was determined as for Fig. 2a,b. Data are represented as box and whiskers plots (whiskers: 10–90 percentile,þ represents
the mean). ***Po0.001; one-way ANOVA (Kruskal-Wallis test, Dunn’s Multiple Comparison Test). Data are from three independent experiments with
450 collisions being tracked per condition. (c,d) H1299 cells were transfected with GFP, GFP-RCP or GFP-RCP435A in combination with siRNAs targeting
LMTK3 (si-LMTK3), LMTK1 (si-LMTK1) or non-targeting control (si-Nt) and plated onto 15 cm plastic dishes. In the right panel of d cells were transfected
with siRNA targeting LMTK3 (si-LMTK3) or non-targeting control in the absence of GFP or GFP-tagged RCPs. Forty-eight hours following transfection, cells
were treated with HGF (10 ngml 1) for the indicated times or were left untreated (0min). Cells were lysed in a buffer containing 0.15% Tween-20 and GFP
or EphA2 immunoprecipitated (IP) as for Fig. 1c. The immunoprecipitates were analysed by immunoblotting using antibodies recognizing EphA2, Rab14,
Rab11, phosphoSer435RCP and RCP. The quantity of phosphoSer435RCP in the immunoblots was estimated by densitometric scanning (c; right panel).
Data are mean±s.e.m. from six independent experiments. ***Po0.001, Mann-Whitney test. Uncropped blots corresponding to the experiments presented
in c,d are displayed in Supplementary Fig. 9.
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more closely associated with tumour dissemination than is the
trafficking of its integrin cargo in tumour cells.
To determine whether reduced metastasis was owing to a
requirement for EphA2 and RCP in invasive/migratory behaviour
of PDAC cells, we isolated a number of cell lines from both
control and knockout primary tumours. Western blotting
confirmed that cells from control tumours expressed both EphA2
and RCP protein, and that genetic disruption of the EPHA2 and
RCP genes led to disappearance of their protein products
(Supplementary Fig. 7c). Cells from control tumours were highly
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invasive, and this was significantly reduced by knockout of
EPHA2 or RCP, consistent with a tumour cell-autonomous role
for these proteins in invasive behaviour (Fig. 7c). Cells derived
from KPC tumours typically form loose colonies with many
migratory cells at the colonies’ edges (Fig. 7d; Supplementary
Fig. 7d). By contrast, cells from RCP and EPHA2 knockout
tumours formed closely-knit colonies with a defined edge and
little indication that cells were able to migrate away from
the colonies (Fig. 7d; Supplementary Fig. 7d)). Importantly,
expression of EphA2-GFP or GFP-RCP restored the scattered
morphology of EPHA2 / and RCP / PDAC cells
respectively, whereas EphA2-GFP897A and GFP-RCP435A were
ineffective in this regard (Fig. 7d). Furthermore, re-expression of
GFP-RCP was able to rescue the scattered phenotype of PDAC
cells despite the somewhat reduced levels of EphA2 that were
observable following RCP knockout (Fig. 7d; Supplementary
Fig. 7c ). These data demonstrate that both RCP and EphA2 are
required for efficient invasion and metastasis of pancreatic cancer,
and indicate the likelihood that both of these proteins and
their phosphorylation-dependent trafficking contribute to cell
repulsion and dissemination of PDAC.
Discussion
LMTKs clearly control endocytic traffic. LMTK1 regulates Rab11
recruitment to neuronal endosomes29 and LMTK3 knockout
leads to locomotor defects in mice which are associated with
impaired endocytic trafficking30. Moreover, LMTK2 controls
receptor transfer between early and recycling endosomes31, which
is the point at which we find RCP/Rab14 to influence EphA2
trafficking. Despite these advances, the mechanism through
which LMTKs control endosomal function has hitherto been
unclear. We show that LMTK3 controls endosomal trafficking by
phosphorylating RCP to alter its preference for GTPase binding.
Previous yeast-2-hybrid and co-immunoprecipitation studies
indicate that Rab11 and Rab14 likely compete for binding to
RCP’s well-characterized Rab-binding domain21, but recent work
indicates a more complicated situation. Mutation of residues in
RCP’s central region (which is distant from the Rab-binding
domain) selectively opposes Rab14 binding22. Consistently, our
data indicate that phosphorylation of a residue in a similar region
promotes Rab14 (but not Rab11) association which, in turn,
promotes RCP’s association with EphA2. Thus although our
observations provide evidence for a molecular mechanism
through which growth factor signalling can switch the Rab
GTPase and cargo preference of a Rab11 effector to favour cell
repulsion, further work will be necessary to establish the allosteric
and intramolecular events through which LMTK3 controls
GTPase and cargo association with RCP.
LMTK3 is a determinant in breast and gastric cancer
aggressiveness32,33. Various molecular explanations have been
offered for this, including the possibility that LMTK3 influences
oestrogen receptor signalling32, and the kinase has been reported
to exert post-transcriptional control over a5b1 integrin levels in
breast cancer cells34. Integrin recycling is controlled by RCP
(ref. 27), and it is possible that in breast cancer cells LMTK3 may
oppose a5b1 degradation by phosphorylating RCP. However,
we do not detect alteration in a5b1 levels following knockdown
of LMTK3, nor do we find that this integrin contributes to
HGF-driven cell:cell repulsion or to metastasis of PDAC in vivo.
Thus although it is possible that LMTK3 may control integrin
trafficking to influence invasiveness in breast cancer, our results
indicate that this kinase contributes to PDAC dissemination and
metastasis primarily via phosphorylation of RCP and regulation
of EphA2 trafficking to promote cell:cell repulsion. We have
recently shown that knockout of RCP in a mouse model of
breast cancer does not oppose metastasis35, indicating that the
contribution made by RCP trafficking to metastasis depends on
the cancer type. Furthermore, cell repulsion not only drives
invasiveness if it occurs in a homotypic fashion, but also can
oppose invasiveness if heterotypic repulsion events involving the
tumour stroma are able to dominate36. Further work will be
necessary to fully elucidate how Eph trafficking drives cell
dissemination in various cancer types.
It would seem natural to propose that endosomal recycling
might contribute to functional Eph signalling by concentrating
the receptor within cell:cell contacts where it encounters its ligand
on neighbouring cells. However, our data are not consistent with
a mechanism such as this. Firstly, knockdown of ephrin-A1
(the cognate EphA2 ligand expressed by H1299 cells) or mutation
of EphA2’s Tyr588 (which opposes ephrin ligand-induced
EphA2 trafficking (Supplementary Fig. 5c)) does not influence
EphA2-dependent cell scattering. Secondly, we have found that
phosphorylation of EphA2 at Ser897—an Ephrin ligand-indepen-
dent event—is key to EphA2’s trafficking through the RCP/Rab14
pathway and its ability to drive cell:cell repulsion. So how does
EphA2 endosomal trafficking contribute to HGF-driven cell:cell
repulsion? Under basal conditions, EphA2 is returned directly to
the plasma membrane (and frequently we observe this to occur
near cell:cell contacts) and the receptor is not transported to
perinuclear RCP-positive endosomes. Surprisingly, our data
indicate that this rapid constitutive internalization and recycling
does not initiate functional EphA2 signalling, but it may help to
maintain a reservoir of EphA2 at cell:cell contacts in preparation
Figure 5 | LMTK3 phosphorylation of RCP is necessary for HGF-driven EphA2 trafficking and cell scattering. (a) H1299 cells were transfected with
siRNAs targeting LMTK3 (si-LMTK3) or a non-targeting control (si-Nt) (left panel). Alternatively cells were transfected with GFP-RCP or GFP-RCP435A
(right panel). Internalization of EphA2 in the presence and absence of HGF was then determined as for Fig. 3b. Values are mean±s.e.m. from three
independent experiments. ***Po0.001 (si-LMTK3þHGF versus si-NtþHGF) **Po0.01 (RCP435AþHGF versus RCPWTþHGF); two-way ANOVA,
Bonferroni post-test. (b) H1299 cells were transfected with EphA2-GFP in combination with mCherry-RCP or mCherry-RCP435A, in the presence or
absence of siRNAs targeting LMTK3 (si-LMTK3) or non-targeting control (si-Nt) as indicated. Trafficking of EphA2-GFP and mCherry-RCPs in the presence
and absence of HGF (added 30min before collecting the movies) was visualized by fluorescence confocal time-lapse microscopy and co-localization was
quantified as for Fig. 3e. Stills were extracted from movies at the indicated time points following the collection of the first frame of the movie, and these
display the region of interest indicated by the white box. Bar, 10mm. Values are mean±s.e.m. from three separate experiments incorporating460 cells per
condition. ***Po0.001; one-way ANOVA (Kruskal-Wallis test, Dunn’s Multiple Comparison Test). (c) H1299 cells were transfected with siRNAs targeting
LMTK3 (si-LMTK3), LMTK1 (si-LMTK1) or a non-targeting control (si-Nt). Alternatively cells were transfected with GFP-RCP or GFP-RCP435A. Cell
scattering in the presence and absence of HGF was then experimentally determined and quantified as for Fig. 2d,e. Scattering is expressed as the
accumulated distance travelled by cells from their starting point over 6 h. In the right panel, GFP-RCP and GFP-RCP435A–expressing cells were plated
subconfluently and the migration speed of non-contacting cells was determined in the presence and absence of HGF. Data are represented as box and
whiskers plots (whiskers: 10–90 percentile,þ represents the mean). ***Po0.001; one-way ANOVA (Kruskal-Wallis test, Dunn’s Multiple Comparison
Test). Data are from three independent experiments with 450 cells being tracked per condition.
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for signals that trigger cell:cell repulsion. Indeed, a recent report
has demonstrated that constitutive transit of EphA2 through
Rab11-positive endosomes brings the receptor into contact with
tyrosine phosphatase PTP1B to ensure that low background levels
of tyrosine phosphorylated EphA2 are maintained in the absence
of ligand-engagement37. This study indicated that engagement of
EphA2 with ephrin-A1 then diverts the receptor from the Rab11
pathway and routes it to Rab7-positive late endosomes. Our data
indicate that a significant fraction of EphA2 is diverted from a
constitutive recycling pathway by activated HGF-signalling, and
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that this requires a signalling event (phosphorylation of Ser897)
that is not associated with EphA2-ephrin engagement at the
plasma membrane. Moreover, the receptor’s destination following
activation of HGF-signalling is not late endosomal, but a subset of
RCP/Rab14-positive endosomes which are located very close to
the nucleus. HGF signalling achieves this by concomitant
activation of two parallel phosphorylation cascades. HGF
activates Akt to phosphorylate EphA2 on Ser897 and, in parallel
with this, HGF signalling promotes LMTK3-mediated
phosphorylation of RCP on Ser435 to favour RCP/Rab14
association and both of these events are necessary to divert
EphA2 through a slower recycling pathway and promote
cytoskeletal responses which enable cells to move apart.
It is interesting to speculate how diversion of EphA2 from a
rapid recycling pathway and into one that increases its dwell-time
within the cell might activate cell:cell repulsion. MT1-MMP-
mediated cleavage of EphA2 has been shown to promote cell
repulsion by permitting internalization of the receptor leading to
its accumulation within perinuclear endosomes to activate Rho
signalling20. Thus, signals downstream of EphA2 that promote
repulsion are likely to be propagated during transit through the
endosomal system at a point that is distant from the plasma
membrane. Many receptors activate their effector signalling
pathways following internalization when they are present in
endosomes. Most pertinently, internalized EphA2 has been
shown to retain the capacity to signal to Rho subfamily
GTPases, which are key to the implementation of cell:cell
repulsion, when the receptor is moving through the endosomal
pathway38. Thus, our data suggest a mechanism in which cell:cell
repulsion is initiated by phosphorylation of serines on RCP and
EphA2 which conspire to divert EphA2 from a rapid recycling
pathway to a slower one involving transit through perinuclear
Rab14-postive endosomes, and it is during this journey that the
receptor engages signalling pathways that drive repulsion (Fig. 8).
Our results have identified a new pathway mechanistically
linking pro-invasive growth factor signalling to cell:cell repulsion.
This is mediated by phosphorylation of a Rab effector to alter its
Rab GTPase preference which, in turn, influences Eph receptor
trafficking (Fig. 8). In parallel with this we have shown that both
RCP and EphA2 are required for efficient invasion and metastasis
in an in vivo model of pancreatic cancer, and to maintain a
cell:cell repulsion phenotype in pancreatic tumour cells ex vivo.
Thus by providing molecular insight into how pro-invasive
signalling initiates cell:cell repulsion, and by showing that
components of this pathway contribute to metastasis in vivo,
we have made an important step into designing therapies that
might interfere with these processes.
Methods
Cell culture and transfection. A2780 cells lines were kindly donated by Gordon
Mills, MD Anderson Cancer Centre, Texas, USA. PC3 cells were kindly provided
by Kate Nobes, University of Bristol, UK. The expression of Ephs and ephrins and
the contribution made by these to cell:cell repulsion in these particular cells has
been characterized19. H1299 cells were obtained from ATCC. The genetic identity
of all these cell lines has been confirmed at the CRUK Beatson Institute for Cancer
Research. Cell lines were cultured at 37 C and 10% CO2 in a humidified incubator.
A2780 and PC3 cells were cultured in RMPI-1640, while H1299 cells and in-house
PDAC cells were cultured in DMEM. All media were supplemented with 10% fetal
calf serum, 2mM L-glutamine, 100 IUml 1 penicillin, 100 mgml 1 streptomycin
and 250 mgml 1 fungizone. Cells were transfected with expression vectors and
siRNAs using the Amaxa Nucleofector system; A2780 cells (kit T), H1299 and PC3
cells (kit V).
Antibodies and immunoprecipitation. For western blotting (WB) and
immunofluorescence (IF), antibodies were from the following sources: mouse
anti-EphA2 (Millipore, catalogue number 05-480, dilution 1:1,000 WB, 1:200 IF),
rabbit anti-FIP2 (Proteintech; catalogue number, 10837-1-AP; dilution 1:500 WB),
rabbit anti-FIP3 (a generous gift from Mary McCaffrey; dilution 1:500 WB), rabbit
anti-phosphoSer435RCP (was raised by immunizing rabbits to KLH-conjugated
RCP427-439(pSer435) followed by affinity purification with the same peptide;
Eurogentech; dilution 1:5,000 WB, 1:200 IF), rabbit anti-Rab11 (Invitrogen;
catalogue number, 71-5300; dilution 1:1,000 WB), rabbit anti-Rab14 (Novus
Biologicals; catalogue number, NBPI 84720; dilution, 1:500 WB), rabbit anti-RCP
(raised against in-house purified RCP379-649; Eurogentech; dilution 1:10,000 WB,
1:3,000 IF), mouse anti-a5 integrin (BD Transduction Labs; catalogue number,
610633; dilution 1:1,000 WB), rabbit anti-EphA2pS897 (Cell Signaling
Technology; catalogue number, 6347; dilution 1:1,000 WB, 1:200 IF) and rabbit
anti-EphA2pY588 (Cell Signaling Technology; catalogue number, 12677; dilution
1:1,000 WB).
Mouse anti-EphA2 (Millipore; catalogue number 05-480) and mouse anti-GFP
(Abcam; catalogue number ab1218) were used for immunoprecipitation. Mouse
anti-GFP or anti-EphA2 was coupled to magnetic beads conjugated to anti-mouse
IgG (Invitrogen; Dynabeads Sheep anti-mouse IgG; catalogue number 11031). Cell
lysates were prepared in a lysis buffer containing 200mM NaCl, 75mM Tris-HCl
pH 7, 15mM NaF, 1.5mM Na3VO4, 7.5mM EDTA, 7.5mM EGTA, 0.15% (v/v)
Tween-20, 50 mgml 1 leupeptin, 50 mgml 1 aprotinin and 1mM
4-(2-aminoethyl)-benzenesulfonyl fluoride. Lysates were passed three times
through a 27-gauge needle and clarified by centrifugation at 10,000g for 10min at
4 C. Lysates were added to the beads and rotated for 2 h at 4 C. The beads were
washed three times in Tween-20-containing buffer, and then analysed for protein
content either by MALDI-TOF mass spectrometry or by immunoblotting.
Figure 6 | Phosphorylation of EphA2 at Ser897 is necessary for HGF-driven EphA2 trafficking and cell scattering. (a) H1299 cells were transfected with
a siRNA targeting EphA2 in combination with siRNA-resistant forms of EphA2-GFP or EphA2897A-GFP. Internalization of EphA2-GFPs in the presence and
absence of HGF was then determined as for Fig. 3b, but with the ELISA plate coated with anti-GFP to specifically detect only the GFP-tagged receptor.
Values are mean±s.e.m. n¼4 biological replicates from two independent experiments. ***Po0.001 (EphA2897A-GFPþHGF versus EphA2-GFPþHGF);
two-way ANOVA, Bonferroni post-test. (b) H1299 cells were transfected with EphA2-GFP or EphA2897A-GFP in combination with mCherry-RCP. Trafficking
of EphA2-GFP and mCherry-RCPs in the presence and absence of HGF (added 30min before collecting the movies) was visualized by fluorescence
confocal time-lapse microscopy and co-localization was quantified as for Fig. 3e. Stills were extracted from movies at the indicated time points, and these
display the region of interest indicated by the white box. Bar, 10mm. Values are mean±s.e.m. from three separate experiments incorporating410 cells per
condition per experiment. ***Po0.001; one-way ANOVA (Kruskal-Wallis test, Dunn’s Multiple Comparison Test). (c) H1299 cells were transfected with
GFP-RCP or GFP-RCP435A, in the presence or absence of siRNAs targeting Rab14 (si-Rab14), LMTK3 (si-LMTK3) or non-targeting control (si-Nt) as
indicated. Cells were incubated in the presence or absence of HGF for 30min and then fixed and phospho-Ser897-EphA2 (EphA2pS897) and nuclei were
visualized by immunofluorescence followed by confocal microscopy. Bar, 10mm. Co-localization of GFP-RCPs and EphA2pS897 was determined as for
Fig. 3e. Values are mean±s.e.m. from three separate experiments incorporating 460 cells per condition. ***Po0.001; one-way ANOVA (Kruskal-Wallis
test, Dunn’s Multiple Comparison Test). (d) H1299 cells were transfected with a non-targeting siRNA or with an siRNA targeting EphA2 (si-EphA2) in
combination with siRNA-resistant forms of EphA2-GFP or EphA2897A-GFP. Cell scattering and the migration of subconfluent, non-contacting cells in the
presence and absence of HGF was then determined and quantified as for Fig. 5c. Data are represented as box and whiskers plots (whiskers: 10–90
percentile,þ represents the mean). ***Po0.001; one-way ANOVA (Kruskal-Wallis test, Dunn’s Multiple Comparison Test). Data are from three
independent experiments with 450 cells being tracked per condition. The expression levels of the siRNA-resistant forms of EphA2-GFP and
EphA2897A-GFP were determined in EphA2 knockdown cells by western blotting with antibodies recognizing EphA2 or pSer897-EphA2. The band marked
with an asterisk is recognized non-specifically by the anti- pSer897-EphA2 antibody. Uncropped blots corresponding to the experiment presented in d are
displayed in Supplementary Fig. 9.
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Internalization assay and capture-ELISA. Cell surface proteins were labelled
with membrane impermeable sulfo-NHS-SS-Biotin (0.13mgml 1) in PBS for
30min at 4 C. To allow internalization, cells were incubated at 37 C for the
appropriate times in the presence and absence of HGF (10 ngml 1) or primaquine
(0.6mM). To remove biotin from proteins remaining at the cell surface, cells were
incubated with sodium mercaptoethanesulphonate (MesNa; 20mM) for 60min at
4 C. Excess MesNa was then quenched by addition of iodoacetamide (20mM) for
a further 10min at 4 C. The plates were washed and lysed in a buffer containing
1.5% Triton X-100 and the levels of biotinylated-EphA2 were determined by
capture-ELISA.
Live cell imaging and fluorescently-tagged EphA2. To image EphA2 trafficking,
the full-length sequence of human EphA2 was inserted into pEGFP-N1 vector
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using the Sal1 (3’) and Xho1 (5’) sites. mCherry-RCP constructs were generated
by subcloning the open reading frame of RCP into pmCherry-C1 (ref. 28).
Transfected cells were seeded onto glass-bottomed plates and, 24 h later,
were viewed using an Olympus FV-1000 microscope. Cells were incubated
in the presence or absence of HGF (10 mgml 1) for 15min and then 2min
movies (6 s frame interval) were collected. Co-localization analyses were
performed using the ImageJ Co-localization Threshold plugin. Briefly, this
plugin automatically determined the threshold intensity levels using the Costes
method39 and subsequently generated the fraction of co-localizing pixels above
the threshold in both channels. Co-localization values are presented as the mean
values of co-localizing pixels at least three experiments, comprising at least ten
randomly chosen cells for each experiment. The same approach was used for
quantification of co-localization between endogenous EphA2pS897 and GFP-RCP
in fixed cells.
Airyscan imaging. Single plane images including the perinuclear region
were acquired using a Zeiss LSM 880 Airyscan confocal microscope.
Images were processed and subject to deconvolution using Zen Black Zeiss
software.
Cell:cell repulsion and scattering assays. To measure cell:cell repulsion,
six-well glass-bottomed plates were coated in 150 ml Matrigel in 300 ml
0.5% Serum RPMI-1640 at room temperature for 1 h. PC3 cells (200 cells per well)
were seeded onto the Matrigel-coated surface and incubated at 37 C for 24 h.
Cells were incubated in serum-reduced medium (0.5% serum) for a further
24 h, and then HGF (10 ngml 1) was added to elicit cell migration. Cell migration
was visualized on a Nikon timelapse microscope. Images were collected every
5min from eight different regions in each well for 20 h. The time of cell-cell
contact during collision was measured for any collision in which only two
cells were involved and both cells were migrating towards each other.
Cell contact was assessed by close inspection of the phase contrast
frames from the movies, and cells were classified as ‘contacting’ if the
envelope of their plasma membranes were closely apposed. Thus this
classification would exclude cells that were connected by fine membranous
contacts or retraction fibres that might remain following a productive
repulsion event.
To measure HGF-induced scattering, H1299 cells (2,000 cells per well)
were seeded onto six-well plates for 48 h, during which time the cells formed
small colonies. Cell movement was then visualized on a Nikon timelapse
microscope in the presence and absence of HGF (10 ngml 1). Images
were collected every 5min from eight different regions in each well.
To track scattering, ImageJ manual tracking and chemotaxis plugins were
used. Every cell that was in a colony of 4-10 cells and did not divide was
tracked for 6 h.
KPC mouse model of PDAC. KPC (Pdx1-Cre, KrasG12D/þ , p53R172H/þ ) mice are
as described in ref. 40. EphA2 / mice were obtained from Jackson laboratories,
and RCPfl/fl mice were generated in-house by the Beatson transgenic production
service. PCR was used to check the genotype of the mice (Transnetyx Inc). ITG5A
floxed mice were a generous gift from Richard Hynes (MIT, USA) and are as
described in ref. 41. Mice were monitored daily and kept in conventional animal
facilities. All experiments were performed in compliance with UK Home Office
guidelines. Tumourigenesis was assessed by gross pathology and confirmed by
histology.
Data availability. The data and reagents that support the findings of this study are
available from the corresponding author on request.
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Figure 8 | Control of EphA2 trafficking during cell scattering. (a) EphA2 is constitutively internalized and returned to the plasma membrane without
transit through RCP-positive endosomes, and RCP is associated primarily with Rab11. (b) Addition of HGF triggers LMTK3-dependent phosphorylation of
RCP at Ser435 which favours RCP’s association with Rab14. In parallel with this, HGF promotes Akt-mediated phosphorylation of EphA2 at Ser897. Both of
these phosphorylation events are necessary to promote diversion of EphA2 from a rapid recycling pathway to a slower one which transits through
RCP/Rab14-positive endosomes, and to enable EphA2-dependent cell:cell repulsion and scattering.
Figure 7 | Knockout of EphA2 or RCP reduces invasion and metastasis in pancreatic cancer in vivo. (a) KPC (Pdx1-Cre:KrasG12D/þ :p53R172H/þ ) mice
were crossed with EPHA2þ / or EPHA2 / animals or those with floxed RCP (RCPþ/fl or RCPfl/fl) or floxed a5 integrin (ITGA5þ /fl or ITGA5fl/fl)
alleles. Survival time (which is dictated by the size of the primary tumour) is represented by a Kaplan-Meier curve. Censored mice (indicated by ticks)
succumbed to complications other than PDAC. (b) The proportion of animals with detectable metastases to liver, lung and other tissues was assessed by
gross pathology and confirmed by histology. The number of animals in each category is indicated above the bars. *Po0.05; Comparison is between
EPHA2þ /þ and EPHA2 / , or between RCPþ/þ and RCPfl/fl; Chi-squared test, one-tailed. ns¼ not significantly different from ITGA5þ /þ control.
(c,d) Primary mouse cell lines were derived from PDACs harvested from KPC (Pdx1-Cre, KrasG12D/þ , p53R172H/þ ), KPC:EPHA2 / and KPC:RCPfl/fl
mice. At least three cell lines were derived per condition and the knockout of EphA2 and RCP was confirmed by immunoblotting (see Supplementary
Fig. 3c). PDAC cells (two cell lines per condition) were plated onto the underside of transwells containing Matrigel plugs enriched with fibronectin
(25mgml 1). Cells were allowed to migrate into the plugs towards a gradient of HGF and serum for 72 h, and then visualized by Calcein-AM followed by
confocal microscopy. Optical sections were taken every 10mm and consecutive images are displayed as a series running from left to right
(c; left panels). Cell invasion beyond 20mm (to the right of the red dashed line) was quantified and expressed as a % of the total quantity of fluorescent
cells in the plug (c; right panel). Data are represented as box and whiskers plots (whiskers: 10–90 percentile). ***Po0.001; one-way ANOVA
(Kruskal-Wallis test, Dunn’s Multiple Comparison Test). Data are from three independent experiments. The EPHA2 #1 knockout PDAC line was stably
transfected with EphA2-GFP or EphA2897A-GFP, and the RCP #2 knockout line was stably transfected with GFP-RCP or GFP-RCP435A as indicated, and the
expression of these GFP-tagged proteins was determined by western blotting. The propensity of these PDAC cells to form tight or scattered colonies was
determined using phase contrast microscopy (d). Bar, 100mm. Lower magnification images of these fields are displayed in Supplementary Fig. 7d.
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